Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The 3 Best Vegan Stocks to Buy in April 2024

By Josh Enomoto, InvestorPlace Contributor

A generation ago, we probably wouldn’t be having this conversation about the best vegan stocks to buy in April. That’s because back in the day,…

The 3 Best Travel Stocks to Buy in April 2024

By Josh Enomoto, InvestorPlace Contributor

While it’s an adventurous idea in more ways than one, if you believe in the lasting power of revenge travel, these ideas for best travel…

3 Utility Stocks to Buy Ahead of Market Jitters

By Josh Enomoto, InvestorPlace Contributor

While the market has enjoyed a good run, a possible consolidation warrants a closer look at utility stocks to buy. Basically, this sector is permanently…

7 Penny Stocks That Deserve a Closer Look in Q2

By Josh Enomoto, InvestorPlace Contributor

For the most extreme opportunities in the market this side of an options trade, your best bet may be to consider penny stocks to watch…

OCGN Stock Alert: Why Is Ocugen Up 20% Today?

By Josh Enomoto, InvestorPlace Contributor

With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.

Load More